Human gene therapy - JoVE Visualize

Showing results (3121-3130 of 4,130) with videos related to

Pageof 413

Sort By:

Human Gene Therapy|March 21, 1998

Ex vivo hepatic gene therapy of a mouse model of Hereditary Tyrosinemia Type IK Overturf, M Al-Dhalimy, K Manning, et al.

Human Gene Therapy|March 21, 1998

Effects of complement depletion on the pharmacokinetics and gene delivery mediated by cationic lipid-DNA complexesL G Barron, K B Meyer, F C Szoka

Human Gene Therapy|March 21, 1998

Plasmid DNA encoding targeted naturally processed peptides generates protective cytotoxic T lymphocyte responses in immunized animalsM L Hedley, J L Strominger, R G Urban

Human Gene Therapy|March 21, 1998

Bone marrow stromal cells as targets for gene therapy of hemophilia AM K Chuah, H Brems, V Vanslembrouck, et al.

Human Gene Therapy|March 21, 1998

Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cellsP L Leopold, B Ferris, I Grinberg, et al.

Human Gene Therapy|August 10, 1997

LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitorsJ A Allay, J E Dennis, S E Haynesworth, et al.

Human Gene Therapy|August 10, 1997

Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapyS Decary, V Mouly, C B Hamida, et al.

Human Gene Therapy|August 10, 1997

Highly efficient retrovirus-mediated gene transfer into rat hepatocytes in vivoO Kitten, F L Cosset, N Ferry

Human Gene Therapy|July 20, 1997

Use of the cosmid adenoviral vector cloning system for the in vitro construction of recombinant adenoviral vectorsS Fu, A B Deisseroth

Human Gene Therapy|June 13, 1998

Quantitation of host cell DNA contaminate in pharmaceutical-grade plasmid DNA using competitive polymerase chain reaction and enzyme-linked immunosorbent assayR Lahijani, M Duhon, E Lusby, et al.

Pageof 413

Showing results (3121-3130 of 4,130) with videos related to

Sort By:

Pageof 413

Human Gene Therapy|March 21, 1998

Ex vivo hepatic gene therapy of a mouse model of Hereditary Tyrosinemia Type IK Overturf, M Al-Dhalimy, K Manning, et al.

Human Gene Therapy|March 21, 1998

Effects of complement depletion on the pharmacokinetics and gene delivery mediated by cationic lipid-DNA complexesL G Barron, K B Meyer, F C Szoka

Human Gene Therapy|March 21, 1998

Plasmid DNA encoding targeted naturally processed peptides generates protective cytotoxic T lymphocyte responses in immunized animalsM L Hedley, J L Strominger, R G Urban

Human Gene Therapy|March 21, 1998

Bone marrow stromal cells as targets for gene therapy of hemophilia AM K Chuah, H Brems, V Vanslembrouck, et al.

Human Gene Therapy|March 21, 1998

Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cellsP L Leopold, B Ferris, I Grinberg, et al.

Human Gene Therapy|August 10, 1997

LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitorsJ A Allay, J E Dennis, S E Haynesworth, et al.

Human Gene Therapy|August 10, 1997

Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapyS Decary, V Mouly, C B Hamida, et al.

Human Gene Therapy|August 10, 1997

Highly efficient retrovirus-mediated gene transfer into rat hepatocytes in vivoO Kitten, F L Cosset, N Ferry

Human Gene Therapy|July 20, 1997

Use of the cosmid adenoviral vector cloning system for the in vitro construction of recombinant adenoviral vectorsS Fu, A B Deisseroth

Human Gene Therapy|June 13, 1998

Quantitation of host cell DNA contaminate in pharmaceutical-grade plasmid DNA using competitive polymerase chain reaction and enzyme-linked immunosorbent assayR Lahijani, M Duhon, E Lusby, et al.

Pageof 413